R
  • 773.714.0705
  • Home
  • About Us
  • Therapeutic Area
  • Activities
    • Live
    • Online
  • Outcomes & Toolkits
New User? Login
Certificate Use Certificate Code
Mitigating Veno-occlusive Disease Risk in Patients Treated for Relapsed/Refractory B-cell Precursor ALL
Mitigating Veno-occlusive Disease Risk in Patients Treated for Relapsed/Refractory B-cell Precursor ALL
Expert Perspectives

Veno-occlusive disease (VOD) is a life-threatening condition associated with treatment of relapsed/refractory B-cell precursor acute lymphoblastic leukemia (R/R ALL). Early recognition and management are paramount to recovery. This self-directed education was designed for diverse members of the interdisciplinary care team that treat or may encounter patients with R/R ALL who are at risk for VOD. Expert commentary from Partow Kebriaei, MD provides answers to common questions faced by clinicians when diagnosing and managing VOD.

Faculty: Partow Kebriaei, MD

Release Date: December 02, 2022

Expiration Date: December 02, 2023

footer-logo

230 W. Monroe Street
Suite 2300
Chicago, IL 60606

  • Phone: 773.714.0705
  • Fax: 773.714.0707
  • Home
  • Therapeutic Areas
  • Sitemap
  • Privacy Policy
  • Contact Us
  • Follow us on Twitter
  • Like us on Facebook
  • Follow us on LinkedIn

Copyright © 2023 Academy for Continued Healthcare Learning. All Rights Reserved.

Processing...
×